SCHEMBL23458092

SCHEMBL23458092

CCN(C)c1c(C(C)C)ccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
NCEH1 Q6PIU2 1/20 0.36
SIGMAR1 Q99720 2/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
HTR2A P28223 2/20 0.36
HTR2C P28335 1/20 0.36
ALDH1A1 P00352 2/20 0.35
CYP2A6 P11509 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
AOC3 Q16853 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29862144 1.00 CYP1A2 (0.37) CYP1A2CYP2D6NCEH1SIGMAR1CYP2C19
SCHEMBL23458213 0.85 CYP1A2 (0.38) CYP1A2CYP2D6NCEH1SIGMAR1CYP2C19
SCHEMBL29862563 0.85 CYP1A2 (0.38) CYP1A2CYP2D6NCEH1SIGMAR1CYP2C19
SCHEMBL23457952 0.82 CYP1A2 (0.36) CYP1A2CYP2D6NCEH1SIGMAR1CYP2C19
SCHEMBL29862416 0.82 CYP1A2 (0.36) CYP1A2CYP2D6NCEH1SIGMAR1CYP2C19
SCHEMBL23457987 0.79 CYP2A6 (0.38) CYP1A2CYP2D6NCEH1SIGMAR1CYP2C19
SCHEMBL29862163 0.79 CYP2A6 (0.38) CYP1A2CYP2D6NCEH1SIGMAR1CYP2C19
SCHEMBL29862287 0.77 CYP1A2 (0.48) CYP1A2CYP2D6SIGMAR1CYP2C19TDP1
SCHEMBL23458378 0.77 CYP1A2 (0.48) CYP1A2CYP2D6SIGMAR1CYP2C19TDP1
SCHEMBL21040956 0.76 GABRA1 (0.43) CYP1A2SIGMAR1HTR2CTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons SICPA HOLDING SA (CH) 2025-12-30 US disclosed
EP-4069806-B1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2025-04-16 EP disclosed
US-20240327736-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2024-10-03 US disclosed
US-12031098-B2 Method of marking a petroleum hydrocarbon SICPA HOLDING SA (CH) 2024-07-09 US disclosed
EP-4069807-B1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-10-04 EP disclosed
US-20230103579-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-04-06 US disclosed
US-20230029106-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2023-01-26 US disclosed
WO-2021110525-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2021-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons CYP4A11, CYP11B1, CYP11A1 CYP1A2 57/4885CYP2D6 336/4885NCEH1 743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.